Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $5.5 million versus the consensus estimate of $5.41 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.